Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1990 | 03-1990 | 12-1989 | 09-1989 | 06-1989 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,603 | N/A | -2,115 | N/A | -2,115 |
| Depreciation Amortization | 123 | N/A | 78 | N/A | 78 |
| Other Working Capital | 639 | N/A | -2,680 | N/A | -2,680 |
| Other Operating Activity | 409 | 0 | 239 | 0 | 239 |
| Operating Cash Flow | $-1,433 | $N/A | $-4,477 | $N/A | $-4,477 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -109 | N/A | -170 | N/A | -170 |
| Net Acquisitions | N/A | N/A | 2,057 | N/A | 2,057 |
| Other Investing Activity | 381 | 0 | 1,080 | 0 | 1,080 |
| Investing Cash Flow | $272 | $N/A | $2,967 | $N/A | $2,967 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -79 | 0 | 1,204 | 0 | 1,204 |
| Financing Cash Flow | $-79 | $N/A | $1,204 | $N/A | $1,204 |
| Beginning Cash Position | 3,007 | N/A | 3,313 | N/A | 3,313 |
| End Cash Position | 1,767 | N/A | 3,007 | N/A | 3,007 |
| Net Cash Flow | $-1,240 | $N/A | $-306 | $N/A | $-306 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,433 | N/A | -4,477 | N/A | -4,477 |
| Free Cash Flow | -1,433 | 0 | -4,477 | 0 | -4,477 |